Dr Peter Hoecherl > Vossius & Partner > Munich, Germany > Lawyer Profile
Vossius & Partner Offices
SIEBERTSTRASSE 3
81675 MÜNCHEN
Germany
- Firm Profile
- Go to...
Dr Peter Hoecherl
Work Department
Chemistry & Pharmacology
Position
PARTNER
Apotheker, Registered Pharmacist
Patentanwalt, European Patent Attorney
UPC Representative
Career
Dr. Peter Hoecherl is a German Patent Attorney (Patentanwalt), a European Patent Attorney and a European Trademark and Design Attorney. He became a partner in the firm VOSSIUS in 2017. He studied Pharmacy and holds a Ph.D. in the field of medicinal chemistry.
Dr. Hoecherl has profound experience in all areas of patent law. His work focuses on prosecution, opposition and revocation proceedings before the European Patent Office (EPO), the German Patent and Trademark Office and the Federal Patent Court. Exemplary inter partes cases of him relate to patents in the field of type-2 diabetes, pancreatic cancer, breast cancer, HIV, autoimmune diseases, pulmonary arterial hypertension, Parkinson’s disease, infant formula, dairy products, tea preparations, fish oil products, fragrances, etc.
His practice also includes the filing of supplementary protection certificates (SPCs), as well as the preparation of due diligence, freedom-to-operate and validity opinions. He is also closely involved in various infringement and revocation proceedings at a national and international level.
His clients include both small and medium-sized companies and research institutions as well as leading global companies, in particular in the pharmaceutical and chemical field.
Dr. Hoecherl gives lectures in Germany and abroad, in particular on the case law of the Boards of Appeal of the EPO, as well as the Unitary Patent and the Unified Patent Court (UPC).
Languages
German, English
Memberships
Patentanwaltskammer, AIPPI, epi
Education
Dr. Hoecherl obtained his Ph.D. in the field of medicinal chemistry, where his research focused on bio-analytical methods and the detection of brain tumors via in-vivo-imaging. He also gained in-house experiences in the production of sterile drugs at the headquarters of a globally leading pharmaceutical company in Basel (Switzerland), as well as at a renowned London law firm.